Children's Hospital of Philadelphia Receives Major Funding to Enhance Gene Editing Therapies Over Five Years#United_States#Philadelphia#Children's_Hospital#Medical_Research#Gene_Editing
Children's Hospital of Philadelphia Receives Major Funding to Enhance Gene Editing Therapies Over Five Years
The Children's Hospital of Philadelphia has secured a significant funding opportunity to develop advanced gene editing therapies for rare genetic disorders over the next five years.
third-news.com
July 9, 2026 at 3:30 PM
Children's Hospital of Philadelphia Receives Major Funding to Enhance Gene Editing Therapies Over Five Years#United_States#Philadelphia#Children's_Hospital#Medical_Research#Gene_Editing
What do the [ETHICS] of [GENE_EDITING] and [TERMINATING] your [CO_WORKER] have in [COMMON]?
Find out [TOMORROW] at [5PM_EST] in [EPISODE_12]!
Find out [TOMORROW] at [5PM_EST] in [EPISODE_12]!
February 11, 2026 at 12:02 AM
What do the [ETHICS] of [GENE_EDITING] and [TERMINATING] your [CO_WORKER] have in [COMMON]?
Find out [TOMORROW] at [5PM_EST] in [EPISODE_12]!
Find out [TOMORROW] at [5PM_EST] in [EPISODE_12]!
DropGenie Secures Funding for Revolutionary Gene Editing Technology#Canada#Montreal#biotechnology#Gene_Editing#DropGenie
DropGenie Secures Funding for Revolutionary Gene Editing Technology
DropGenie has announced the completion of Seed+ financing to enhance its gene editing technology, promising quicker insights and lowered experimentation costs.
third-news.com
June 22, 2026 at 12:23 PM
DropGenie Secures Funding for Revolutionary Gene Editing Technology#Canada#Montreal#biotechnology#Gene_Editing#DropGenie
“PROTEUS can produce mammalian-specific adaptations that we wouldn’t have predicted or evolved in other systems…”
Gee, what could possibly go wrong? #Science #Biology #Gene_Editing
spectrum.ieee.org/proteus-mamm...
Gee, what could possibly go wrong? #Science #Biology #Gene_Editing
spectrum.ieee.org/proteus-mamm...
What Makes PROTEUS a Biological AI Machine?
Meet PROTEUS: A virus-inspired machine that could transform gene-editing tools and mRNA medicines. Can AI be made of mammalian cells?
spectrum.ieee.org
July 28, 2025 at 8:21 PM
“PROTEUS can produce mammalian-specific adaptations that we wouldn’t have predicted or evolved in other systems…”
Gee, what could possibly go wrong? #Science #Biology #Gene_Editing
spectrum.ieee.org/proteus-mamm...
Gee, what could possibly go wrong? #Science #Biology #Gene_Editing
spectrum.ieee.org/proteus-mamm...
World's First Gene-Editing Therapy for Hyperlipidemia Approved#China#Shanghai#Gene_Editing#CorrectSequence#APOC3
World's First Gene-Editing Therapy for Hyperlipidemia Approved
CorrectSequence Therapeutics announces a groundbreaking gene-editing treatment targeting APOC3 for hyperlipidemia, marking a significant medical milestone.
third-news.com
November 7, 2025 at 1:40 PM
World's First Gene-Editing Therapy for Hyperlipidemia Approved#China#Shanghai#Gene_Editing#CorrectSequence#APOC3
Gene Editing Market Forecast to Achieve $30.5 Billion by 2033, Driven by CRISPR Innovations#London#United_Kingdom#Precision_Medicine#Gene_Editing#CRISPR
Gene Editing Market Forecast to Achieve $30.5 Billion by 2033, Driven by CRISPR Innovations
The gene editing market is expected to soar to $30.5 billion by 2033, propelled by advancements in precision medicine and CRISPR technologies.
third-news.com
July 7, 2026 at 2:42 PM
Gene Editing Market Forecast to Achieve $30.5 Billion by 2033, Driven by CRISPR Innovations#London#United_Kingdom#Precision_Medicine#Gene_Editing#CRISPR
Pusan National University Develops Tool Enhancing CRISPR Off-Target Predictions for Diverse Genetic Variants#South_Korea#Pusan_National_University#Busan#Gene_Editing#CRISPR
Pusan National University Develops Tool Enhancing CRISPR Off-Target Predictions for Diverse Genetic Variants
Researchers from Pusan National University have unveiled a groundbreaking web tool designed to enhance CRISPR off-target predictions through individual genetic variations, improving the safety and accuracy of gene editing.
third-news.com
July 2, 2025 at 12:40 PM
Pusan National University Develops Tool Enhancing CRISPR Off-Target Predictions for Diverse Genetic Variants#South_Korea#Pusan_National_University#Busan#Gene_Editing#CRISPR
The Jackson Laboratory and Partners Awarded $34.5 Million to Boost Gene Editing for Pediatric Neurological Disorders#United_States#Gene_Editing#Broad_Institute#Jackson_Laboratory#Bar_Harbor
The Jackson Laboratory and Partners Awarded $34.5 Million to Boost Gene Editing for Pediatric Neurological Disorders
The Jackson Laboratory, alongside the Broad Institute, has secured a significant ARPA-H THRIVE award to develop a gene editing platform aimed at pediatric epilepsy and rare central nervous system diseases.
third-news.com
July 9, 2026 at 3:28 PM
The Jackson Laboratory and Partners Awarded $34.5 Million to Boost Gene Editing for Pediatric Neurological Disorders#United_States#Gene_Editing#Broad_Institute#Jackson_Laboratory#Bar_Harbor
We hebben het systeem afgekeken van bacteriën, die het gebruiken om zich te verdedigen tegen fagen, maar wat een mooie tool om genetische defecten te corrigeren.
Eerste klinische trial dus binnenkort van start!
#CrisprCas9 #sikkelcelanemie #gene_editing
www.nrc.nl/nieuws/2023/...
Eerste klinische trial dus binnenkort van start!
#CrisprCas9 #sikkelcelanemie #gene_editing
www.nrc.nl/nieuws/2023/...
De eerste behandeling met de genetische techniek crispr-cas is goedgekeurd
Sikkelcelziekte: Voor het eerst is er goedkeuring voor een medische behandeling met de genetische techniek crispr-cas9. Dat is een mijlpaal. Een ernstige…
www.nrc.nl
December 15, 2023 at 5:04 PM
We hebben het systeem afgekeken van bacteriën, die het gebruiken om zich te verdedigen tegen fagen, maar wat een mooie tool om genetische defecten te corrigeren.
Eerste klinische trial dus binnenkort van start!
#CrisprCas9 #sikkelcelanemie #gene_editing
www.nrc.nl/nieuws/2023/...
Eerste klinische trial dus binnenkort van start!
#CrisprCas9 #sikkelcelanemie #gene_editing
www.nrc.nl/nieuws/2023/...
#sgu #theSkepticsGuideToTheUniverse:
The Skeptics Guide #1026 - Mar 8 2025
Quickie with Bob: Atlantic #shutdown; News Items: #measles Outbreak, Reintroducing #wolves, TIGR-Tas #gene_editing, #blood_donor Who Saved Millions Dies, #star_mergers; Who's That Noisy; Your Questions and E-mails […]
The Skeptics Guide #1026 - Mar 8 2025
Quickie with Bob: Atlantic #shutdown; News Items: #measles Outbreak, Reintroducing #wolves, TIGR-Tas #gene_editing, #blood_donor Who Saved Millions Dies, #star_mergers; Who's That Noisy; Your Questions and E-mails […]
Original post on mastodon.social
mastodon.social
March 8, 2025 at 3:36 PM
#sgu #theSkepticsGuideToTheUniverse:
The Skeptics Guide #1026 - Mar 8 2025
Quickie with Bob: Atlantic #shutdown; News Items: #measles Outbreak, Reintroducing #wolves, TIGR-Tas #gene_editing, #blood_donor Who Saved Millions Dies, #star_mergers; Who's That Noisy; Your Questions and E-mails […]
The Skeptics Guide #1026 - Mar 8 2025
Quickie with Bob: Atlantic #shutdown; News Items: #measles Outbreak, Reintroducing #wolves, TIGR-Tas #gene_editing, #blood_donor Who Saved Millions Dies, #star_mergers; Who's That Noisy; Your Questions and E-mails […]
Don’t miss out! Poster submissions close June 30, 2024 11:59h AEST. Submit an Abstract for a presentation @BMH2024Melb. Join colleagues from over 40 countries and a truly amazing line-up of presenters. #Gene_Editing, #RNA_Technology, #Climate_Change, # Synthetic_Biology.
November 20, 2024 at 4:16 PM
Don’t miss out! Poster submissions close June 30, 2024 11:59h AEST. Submit an Abstract for a presentation @BMH2024Melb. Join colleagues from over 40 countries and a truly amazing line-up of presenters. #Gene_Editing, #RNA_Technology, #Climate_Change, # Synthetic_Biology.
We switch to the #biotechnology session at the #SOL2024 with a presentation by Jae-Yean Kim who will be talking about precise #gene_editing in tomato. They have developed super-infective agrobacterium using ternary vector to increase % of transformation. HDR-GE technology is still challenging.
November 25, 2024 at 6:26 AM
We switch to the #biotechnology session at the #SOL2024 with a presentation by Jae-Yean Kim who will be talking about precise #gene_editing in tomato. They have developed super-infective agrobacterium using ternary vector to increase % of transformation. HDR-GE technology is still challenging.
Abu Dhabi and Children's Hospital of Philadelphia Join Forces to Enhance Gene Editing for Rare Diseases#Abu_Dhabi#United_Arab_Emirates#Children's_Hospital#Gene_Editing
Abu Dhabi and Children's Hospital of Philadelphia Join Forces to Enhance Gene Editing for Rare Diseases
The Department of Health in Abu Dhabi teams up with Children's Hospital of Philadelphia to advance gene editing techniques for rare diseases through specialized training and innovative collaboration.
third-news.com
June 24, 2026 at 8:13 PM
Abu Dhabi and Children's Hospital of Philadelphia Join Forces to Enhance Gene Editing for Rare Diseases#Abu_Dhabi#United_Arab_Emirates#Children's_Hospital#Gene_Editing
METiS TechBio Unveils Groundbreaking Cardiomyocyte Delivery Data at CRS 2026#China#Beijing#Gene_Editing#METiS_TechBio#cardiomyocyte
METiS TechBio Unveils Groundbreaking Cardiomyocyte Delivery Data at CRS 2026
METiS TechBio showcases innovative data on cardiomyocyte delivery at CRS 2026, unveiling advancements in targeted gene therapies using AI-driven technology.
third-news.com
May 20, 2026 at 11:14 AM
METiS TechBio Unveils Groundbreaking Cardiomyocyte Delivery Data at CRS 2026#China#Beijing#Gene_Editing#METiS_TechBio#cardiomyocyte
FDA's New Framework Accelerates Personalized Gene Editing for Urea Cycle Disorders#United_States#Philadelphia#FDA#Gene_Editing#Urea_Cycle
FDA's New Framework Accelerates Personalized Gene Editing for Urea Cycle Disorders
Recent advancements at CHOP and Penn Medicine, utilizing the FDA's plausible mechanism framework, promise a revolutionary approach to treating urea cycle disorders with personalized gene editing.
third-news.com
March 31, 2026 at 5:07 PM
FDA's New Framework Accelerates Personalized Gene Editing for Urea Cycle Disorders#United_States#Philadelphia#FDA#Gene_Editing#Urea_Cycle
ERS Genomics Unveils Early Access Express License for Innovators#Ireland#Dublin#Gene_Editing#CRISPR#ERS_Genomics
ERS Genomics Unveils Early Access Express License for Innovators
ERS Genomics has introduced its Early Access Express License to provide founders and teams affordable access to CRISPR/Cas9 technology for research purposes.
third-news.com
February 24, 2026 at 12:23 PM
ERS Genomics Unveils Early Access Express License for Innovators#Ireland#Dublin#Gene_Editing#CRISPR#ERS_Genomics
Origin Agritech's Hi3 Gene Editing Technology Recognized as Major Progress in Chinese Agricultural Science 2025#China#Beijing#Origin_Agritech#Gene_Editing#Hi3_technology
Origin Agritech's Hi3 Gene Editing Technology Recognized as Major Progress in Chinese Agricultural Science 2025
Origin Agritech's cutting-edge Hi3 gene editing technology has been recognized as one of the top advancements in Chinese agricultural science for 2025, showcasing its commercial potential.
third-news.com
December 2, 2025 at 12:28 PM
Origin Agritech's Hi3 Gene Editing Technology Recognized as Major Progress in Chinese Agricultural Science 2025#China#Beijing#Origin_Agritech#Gene_Editing#Hi3_technology
Moligo Technologies and Cellectis Unveil Groundbreaking DNA Technology for Gene Editing#Sweden#Stockholm#Gene_Editing#Cellectis#Moligo
Moligo Technologies and Cellectis Unveil Groundbreaking DNA Technology for Gene Editing
Moligo Technologies, in collaboration with Cellectis, reveals promising results for non-viral gene editing using enzymatically synthesized single-stranded DNA, as published in Nature Communications.
third-news.com
November 21, 2025 at 12:51 PM
Moligo Technologies and Cellectis Unveil Groundbreaking DNA Technology for Gene Editing#Sweden#Stockholm#Gene_Editing#Cellectis#Moligo
Cancer Gene Therapy Market Anticipated to Reach $19.97 Billion by 2033 with Rapid Growth#United_States#Austin#Immunotherapy#Gene_Editing#Cancer_Gene_Therapy
Cancer Gene Therapy Market Anticipated to Reach $19.97 Billion by 2033 with Rapid Growth
The cancer gene therapy market is set to expand significantly, projected to reach $19.97 billion by 2033, with advances in treatment methods fostering growth.
third-news.com
September 15, 2025 at 3:22 PM
Cancer Gene Therapy Market Anticipated to Reach $19.97 Billion by 2033 with Rapid Growth#United_States#Austin#Immunotherapy#Gene_Editing#Cancer_Gene_Therapy
iNtRON Bio Makes Strides in Gene Editing with New IMPA™ Technology Applications#South_Korea#Seoul#Gene_Editing#iNtRON_Bio#IMPA_technology
iNtRON Bio Makes Strides in Gene Editing with New IMPA™ Technology Applications
iNtRON Bio recently filed two patents for its novel IMPA™ gene editing technology, aiming to revolutionize bacteriophage applications in medicine.
third-news.com
August 26, 2025 at 2:40 PM
iNtRON Bio Makes Strides in Gene Editing with New IMPA™ Technology Applications#South_Korea#Seoul#Gene_Editing#iNtRON_Bio#IMPA_technology
O'Shaughnessy Ventures Awards $100K Fellowship for Aging Biology Research#Gene_Editing#O'Shaughnessy_Ventures#Benjamin_Arya
O'Shaughnessy Ventures Awards $100K Fellowship for Aging Biology Research
The O'Shaughnessy Fellowship honors Benjamin Arya with $100,000 to enhance gene-engineering tools aimed at combating aging.
third-news.com
July 2, 2025 at 12:42 PM
O'Shaughnessy Ventures Awards $100K Fellowship for Aging Biology Research#Gene_Editing#O'Shaughnessy_Ventures#Benjamin_Arya
YolTech Therapeutics Achieves FDA Clearance for Revolutionary Gene-Editing Therapy YOLT-101#Shanghai#None#Gene_Editing#YolTech#YOLT-101
YolTech Therapeutics Achieves FDA Clearance for Revolutionary Gene-Editing Therapy YOLT-101
YolTech Therapeutics has received FDA approval for YOLT-101, a groundbreaking gene-editing therapy aimed at treating familial hypercholesterolemia, marking a pivotal moment in biotechnology.
third-news.com
June 6, 2025 at 3:56 AM
YolTech Therapeutics Achieves FDA Clearance for Revolutionary Gene-Editing Therapy YOLT-101#Shanghai#None#Gene_Editing#YolTech#YOLT-101
Weekly Update: Must-Read Health Announcements from PR Newswire#United_States#New_York#Gene_Editing#FDA_Approvals#Health_Press_Release
Weekly Update: Must-Read Health Announcements from PR Newswire
This week’s recap highlights essential health press releases, covering breakthroughs in gene therapy, product approvals, and investment in healthcare innovation.
third-news.com
May 16, 2025 at 10:24 AM
Weekly Update: Must-Read Health Announcements from PR Newswire#United_States#New_York#Gene_Editing#FDA_Approvals#Health_Press_Release
CellFE and Made Scientific Join Forces to Revolutionize Non-viral Gene Editing in T Cell Therapies#USA#Gene_Editing#CellFE#Made_Scientific#Alameda,_California;_Princeton,_New_Jersey
CellFE and Made Scientific Join Forces to Revolutionize Non-viral Gene Editing in T Cell Therapies
CellFE and Made Scientific have entered a strategic collaboration aimed at pioneering non-viral gene editing techniques for enhanced T cell therapies, making innovative treatments more widely accessible.
third-news.com
May 13, 2025 at 4:48 PM
CellFE and Made Scientific Join Forces to Revolutionize Non-viral Gene Editing in T Cell Therapies#USA#Gene_Editing#CellFE#Made_Scientific#Alameda,_California;_Princeton,_New_Jersey
AccurEdit Therapeutics to Present Groundbreaking Research at ASGCT 2025#United_States#New_Orleans#Gene_Editing#AccurEdit#ART001
AccurEdit Therapeutics to Present Groundbreaking Research at ASGCT 2025
AccurEdit Therapeutics will showcase its innovative abstracts at the 2025 ASGCT, highlighting advances in gene editing technology and its pivotal ART001 therapy.
third-news.com
May 12, 2025 at 12:43 PM
AccurEdit Therapeutics to Present Groundbreaking Research at ASGCT 2025#United_States#New_Orleans#Gene_Editing#AccurEdit#ART001